Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia

[1]  M. Vinberg,et al.  Measurements of brain-derived neurotrophic factor: Methodological aspects and demographical data , 2007, Brain Research Bulletin.

[2]  M. Berk,et al.  Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder , 2007, Neuroscience Letters.

[3]  J. González,et al.  Brain-Derived Neurotrophic Factor Val66Met and Psychiatric Disorders: Meta-Analysis of Case-Control Studies Confirm Association to Substance-Related Disorders, Eating Disorders, and Schizophrenia , 2007, Biological Psychiatry.

[4]  P. Buckley,et al.  Brain derived neurotropic factor in first-episode psychosis , 2007, Schizophrenia Research.

[5]  Chien-Te Lee,et al.  Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients. , 2006, Journal of psychiatric research.

[6]  J. Kleinman,et al.  Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia , 2005, Molecular Psychiatry.

[7]  X. Zhang,et al.  Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics , 2005, Neuroscience Letters.

[8]  Abraham Weizman,et al.  The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia , 2005, European Neuropsychopharmacology.

[9]  X. Zhang,et al.  Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements , 2005, Schizophrenia Research.

[10]  H. Danker-Hopfe,et al.  Brain-derived neurotrophic factor serum concentrations are increased in drug-naïve schizophrenic patients with chronic cannabis abuse and multiple substance abuse , 2004, Neuroscience Letters.

[11]  J. Thome,et al.  Neurotrophic factors and the pathophysiology of schizophrenic psychoses , 2004, European Psychiatry.

[12]  F. Taneli,et al.  Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[13]  K. Hashimoto,et al.  Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls , 2003, Neuroscience Letters.

[14]  P. Emson,et al.  Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[15]  M. Schwald,et al.  Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets , 2002, Neuroscience Letters.

[16]  H. Nawa,et al.  Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients , 2002, Psychiatry Research.

[17]  Robert Zöchling,et al.  Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses , 2001, Schizophrenia Research.

[18]  G. Pearlson.  Neurobiology of schizophrenia , 2000 .

[19]  K Maeda,et al.  Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients , 2000, Molecular Psychiatry.

[20]  D. Weinberger,et al.  From neuropathology to neurodevelopment , 1995, The Lancet.

[21]  G. Yancopoulos,et al.  BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra , 1991, Nature.

[22]  T. Crow.  Positive and Negative Schizophrenic Symptoms and the Role of Dopamine , 1980, British Journal of Psychiatry.

[23]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[24]  D. Souza,et al.  Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. , 2007, Journal of psychiatric research.

[25]  J. Kleinman,et al.  Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia , 2003, Molecular Psychiatry.

[26]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[27]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.